These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 1539332)

  • 1. The bile-acid-independent flow is reduced in the transplanted liver.
    Friman S; Persson H; Karlberg I; Svanvik J
    Transplant Proc; 1992 Feb; 24(1):396-7. PubMed ID: 1539332
    [No Abstract]   [Full Text] [Related]  

  • 2. Patterns of bile salts and biliary lipids early after liver transplantation differentiate patients with unfavorable graft outcome.
    Tisone G; Angelico M; Baiocchi L; Nistri A; Pisani F; Gandin C; Romagnoli J; Anselmo A; Umberto Casciani C
    Transplant Proc; 1996 Jun; 28(3):1655-6. PubMed ID: 8658824
    [No Abstract]   [Full Text] [Related]  

  • 3. Biliary secretion of bile acids and lipids in primary sclerosing cholangitis. Influence of cholestasis and effect of ursodeoxycholic acid treatment.
    Stiehl A; Rudolph G; Sauer P; Theilmann L
    J Hepatol; 1995 Sep; 23(3):283-9. PubMed ID: 8550992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early graft function in liver transplantation patients.
    Ericzon BG
    Transplant Proc; 1994 Dec; 26(6):3276-8. PubMed ID: 7527965
    [No Abstract]   [Full Text] [Related]  

  • 5. Biliary lipid secretion early after liver transplantation.
    Ericzon BG; Eusufzai S; Kubota K; Einarsson K; Angelin B
    Transplant Proc; 1990 Aug; 22(4):1537-8. PubMed ID: 1975138
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of ursodeoxycholic acid treatment on primary biliary cirrhosis].
    Raedsch R; Stiehl A; Hopf U; Möller B
    Z Gastroenterol Verh; 1989 Jul; 24():125-7. PubMed ID: 2474923
    [No Abstract]   [Full Text] [Related]  

  • 7. Qualitative patterns of biliary bile acids affect cyclosporine intestinal absorption in liver transplant recipients.
    Romagnoli J; Baiocchi L; Tisone G; Angelico M; Pisani F; Negrini S; Iaria G; Nistri A; Casciani CU
    Transplant Proc; 1996 Dec; 28(6):3129-30. PubMed ID: 8962212
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of ursodeoxycholic acid on serum liver enzymes and bile acid metabolism in chronic active hepatitis: a dose-response study.
    Crosignani A; Battezzati PM; Setchell KD; Camisasca M; Bertolini E; Roda A; Zuin M; Podda M
    Hepatology; 1991 Feb; 13(2):339-44. PubMed ID: 1671665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bile acid-independent bile flow is differently regulated by glucagon and secretin in humans after orthotopic liver transplantation.
    Lenzen R; Elster J; Behrend C; Hampel KE; Bechstein WO; Neuhaus P
    Hepatology; 1997 Nov; 26(5):1272-81. PubMed ID: 9362372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The bile acid independent flow is reduced in the transplanted liver.
    Friman S; Persson H; Karlberg I; Svanvik J
    Transpl Int; 1992; 5 Suppl 1():S163-7. PubMed ID: 14621764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant treatment with ursodeoxycholic acid reduces acute rejection after liver transplantation.
    Friman S; Persson H; Scherstén T; Svanvik J; Karlberg I
    Transplant Proc; 1992 Feb; 24(1):389-90. PubMed ID: 1539328
    [No Abstract]   [Full Text] [Related]  

  • 12. A two-year prospective study of the effect of ursodeoxycholic acid on urinary bile acid excretion and liver morphology in cystic fibrosis-associated liver disease.
    Lindblad A; Glaumann H; Strandvik B
    Hepatology; 1998 Jan; 27(1):166-74. PubMed ID: 9425933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Examination of lymph and bile composition following experimental liver transplantation in rat.
    Jakab F; Sugár I; Závodszky Z; Metzger P; Ughy T
    Acta Chir Hung; 1987; 28(4):337-43. PubMed ID: 3324592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conditioning of liver grafts with prostaglandins improves bile acid transport.
    Farkas S; Bolder U; Schlittenbauer T; Obed A; Zuelke C; Anthuber M; Geissler EK; Schlitt HJ
    Transplant Proc; 2005; 37(1):435-8. PubMed ID: 15808668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Medical treatment of gallstones (author's transl)].
    Gérolami A; Montet JC; Marteau C; Reynier MO; Crotte C
    Gastroenterol Clin Biol; 1980; 4(8-9):588-99. PubMed ID: 7000610
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of the effects between ursodeoxycholic and chenodeoxycholic acids on liver function and structure and bile acid composition in the Rhesus Monkey.
    Sarva RP; Fromm H; Farivar S; Sembrat RF; Mendelow H; Shinozuka H; Wolfson SK
    Gastroenterology; 1980 Oct; 79(4):629-36. PubMed ID: 7409382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intractable diarrhea after liver transplantation for Byler's disease: successful treatment with bile adsorptive resin.
    Egawa H; Yorifuji T; Sumazaki R; Kimura A; Hasegawa M; Tanaka K
    Liver Transpl; 2002 Aug; 8(8):714-6. PubMed ID: 12149765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bile acids analysis: a tool to assess graft function in human liver transplantation.
    Vilca Melendez H; Rela M; Setchell KD; Murphy GM; Heaton ND
    Transpl Int; 2004 Jul; 17(6):286-92. PubMed ID: 15205724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum bile acids and ursodeoxycholic acid treatment in cystic fibrosis-related liver disease.
    O'Brien SM; Campbell GR; Burke AF; Maguire OC; Rowlands BJ; FitzGerald MX; Hegarty JE
    Eur J Gastroenterol Hepatol; 1996 May; 8(5):477-83. PubMed ID: 8804877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New therapeutical indications of ursodeoxycholic acid.
    Copaci I; Micu L; Iliescu L; Voiculescu M
    Rom J Gastroenterol; 2005 Sep; 14(3):259-66. PubMed ID: 16200237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.